ArticleOncotarget2015

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.

Antonella Bresin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.